Legal Opinion

Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.

District Court, D. Delaware

Decided April 28, 2025No. 1:22-cv-00336Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ALNYLAM PHARMACEUTICALS, INC., Plaintiff, V. Civil Action No. 22-336-CFC (consolidated) PFIZER, INC., PHARMACIA & UPJOHN CO. LLC, BIONTECH SE, and BIONTECH MANUFACTURING GMBH, Defendants. MEMORANDUM ORDER In these consolidated actions, Plaintiff Alnylam Pharmaceuticals, Inc. alleges that COVID-19 vaccines manufactured by Defendants Pfizer, Inc, Pharmacia & Upjohn Co. LLC, BioNTech SE, and BioNTech Manufacturing GmbH infringe certain claims of five Alnylam patents. Each asserted claim claims, among other things, a “cationic…

2Cases cited3 opinions

  1. Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
  2. 02 Micro International Ltd. v. Beyond Innovation Technology Co.Court of Appeals for the Federal Circuit · 2008
  3. Nuance Communications, Inc. v. ABBYY USA Software House, Inc.Court of Appeals for the Federal Circuit · 2016

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API